Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Assessment of hereditary angioedema treatment risks
Shana Kalaria,
Timothy Craig
Department of Medicine
Department of Pediatrics
Division of Pulmonary, Allergy and Critical Care Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
48
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Assessment of hereditary angioedema treatment risks'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Hereditary Angioedema
100%
Adverse Event
71%
Isoniazid
57%
Thrombosis
42%
Fresh Frozen Plasma
42%
Androgen
28%
Hepatocellular Carcinoma
28%
Thromboembolism
28%
Complement Component C1s Inhibitor
28%
Metastatic Carcinoma
14%
Embolism
14%
Anaphylaxis
14%
Keyphrases
Hereditary Angioedema
100%
Adverse Events
57%
C1 Inhibitor
57%
Fresh Frozen Plasma
42%
Androgens
28%
Thrombosis
28%
Hepatocellular Carcinoma
28%
Carcinoma
14%
Adverse Effects
14%
C1 Esterase Inhibitor
14%
Emboli
14%
Anaphylaxis
14%
Internet-based Survey
14%
Abnormal Events
14%
Danazol
14%
Thrombosis Risk
14%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Adverse Event
71%
Isoniazid
57%
Thrombosis
42%
Androgen
28%
Liver Cell Carcinoma
28%
Complement Component C1s Inhibitor
28%
Thromboembolism
28%
Metastasis
14%
Anaphylaxis
14%
Danazol
14%
Embolism
14%